je.st
news
Keryx drug for dialysis patients poised to challenge Genzyme
2014-12-30 21:36:54| Biotech - Topix.net
Greg Madison assumed the role of COO at Keryx Biopharmaceuticals in February, and today he oversees the 50-employee Boston office. With the its newly-approved drug for kidney dialysis patients now being shipped and available to be prescribed, Keryx Biopharmaceuticals is poised to take on one of Genzyme's drugs with sales of about $600 million.
Tags: drug
challenge
patients
poised
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||